Comparative Performance of Latest-Generation and FDA-Cleared Serology Tests for the Diagnosis of Chagas Disease-Reference-Cited by-同舟云学术

Comparative Performance of Latest-Generation and FDA-Cleared Serology Tests for the Diagnosis of Chagas Disease

Published:2021-05-19 Issue:6 Volume:59 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Kelly Emily A.¹,Bulman Christina A.²,Gunderson Emma L.²,Irish Amanda M.³,Townsend Rebecca L.⁴,Sakanari Judy A.²,Stramer Susan L.⁴,Bern Caryn³,Whitman Jeffrey D.⁵

Affiliation:

1. School of Medicine, University of California, San Francisco, San Francisco, California, USA

2. Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA

3. Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA

4. Scientific Affairs, American Red Cross, Gaithersburg, Maryland, USA

5. Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA

Abstract

Confirmed diagnosis of chronic Chagas disease (CD) requires positive results by two different IgG serology tests. Variable sensitivity has been reported among tests and in different regions of endemicity.

Funder

Chan Zuckerberg BioHub

Fundación Mundo Sano

HHS | NIH | National Heart, Lung, and Blood Institute

UC | University of California, San Francisco

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00158-21

Reference37 articles.